Year	Name	Title
2021-2023	Filip Bednar, MD, PhD Regents of the University of Michigan Ann Arbor, MI	Epigenetic Regulation of the Pancreatic Cancer Metabolism
2021-2023	Neha Goel, MD University of Miami Miami, FL	Characterizing the Impact of Genetic Ancestry and Multilevel Social Determinants of Health on Epigenomic Patterns and Signatures Driving Disparate Breast Cancer Outcomes
2021-2023	Jesse D. Vrecenak, MD Washington University in St. Louis St. Louis, MO	Gut-Directed In Utero Cellular Therapy for Cystic Fibrosis
2020-2022	Ian E. Brown, MD, PhD University of California Davis Medical Center Sacramento, CA	The Role and Regulation of P-selectin in Acute Pulmonary Arterial Thrombosis following Blunt Thoracic Trauma
2020-2022	Eric G. Sheu, MD, PhD Brigham and Women's Hospital Boston, MA	Characterization of a Novel, Gut-Restricted Metabolite That Links the Microbiome and the Anti-Diabetic Effects of Bariatric Surgery
2020-2022	Heather Wachtel, MD University of Pennsylvania Philadelphia, PA	Genomic Profiles and Targeted Therapy for Malignant Pheochromocytoma and Paraganglioma
2019-2021	Rohit Chandwani, MD, PhD Weill Cornell Medicine New York, NY	Memory of Inflammation in the Pre-Neoplastic Pancreas
2019-2021	Jonathan D. Spicer, MD, PhD, FRCSC Research Institute of the McGill University Health Center Montreal, QC Canada	Targeting Neutrophils as a Novel Therapeutic Adjuncts to the Treatment of Non-Small Cell Lung Cancer Patients
2019-2021	David H. Stitelman, MD Yale University New Haven, CT	Fetal Gene Editing for Hemoglobinopathies
2018-2020	William H. Kitchens, Jr., MD, PhD Emory University Atlanta, Georgia	Rap1-Interacting Adaptor Molecule (RIAM) as a New Target for Transplant Immunosuppression
2018-2020	Colin A. Martin, MD University of Alabama at Birmingham Birmingham, Alabama	Early Microbial Influence of IgA Secretion and Immune Development
2018-2020	George Plitas, MD Memorial Sloan Kettering Cancer Center New York, New York	CD177 Identifies a Novel Subset of Regulatory T Cells (Treg) Infiltrating Human Breast Cancer
2017-2019	Matthew Delano, MD, PhD University of Michigan Ann Arbor, MI	Immune Impact of Type 2 Diabetes Mellitus on Severe Sepsis Outcomes
2017-2019	Joseph Scalea, MD University of Maryland Baltimore, MD	Transplantation Tolerance without the Risks of Bone Marrow Transplantation: Eliminating the Need for Hematopoietic Stem Cells by Using Regulatory Myeloid Cells and Novel Biomarkers
2017-2019	Mohamed Zayed, MD, PhD Washington University School of Medicine St. Louis, MO	Targeting Diabetic Peripheral Arterial Disease Phospholipogenesis
2016-2018	Vatche G. Agopian, MD University of California, Los Angeles Los Angeles, CA	Molecular Analysis of Circulating Tumor Cells as a Prognostic Biomarker in Hepatocellular Carcinoma
2016-2018	Genevieve M. Boland, MD Massachusetts General Hospital Boston, MA	Analysis of Circulating Exosomes in Melanoma Responders/Non-responders to Immunotherapy
2015-2017	Todd W. Costantini, MD University of California San Diego San Diego, CA	A Human-Specific Mechanism Gauging Neuroinflammation and its Implications for Vagal Nerve Therapeutics
2015-2017	Paige Porrett, MD, PhD University of Pennsylvania Philadelphia, PA	Genesis and Regulation of Pregnancy-induced Anti-fetal T cell Memory
2015-2017	Brian R. Untch, MD Memorial Sloan Kettering Cancer Center New York, NY	Adaptive and Acquired Resistance Mechanisms to the Therapeutic Targeting of Hras in Thyroid Cancer
2014-2016	Karin M. Hardiman, MD, PhD University of Michigan Ann Arbor, Michigan	Molecular Approaches to Improving Rectal Cancer Care
2014-2016	Shirling Tsai, MD University of Texas Southwestern Medical Center Dallas, Texas	Control of TGF-beta signaling by LRP1 in the pathogenesis of aortic aneurysms
2014-2016	Daniel S. Eiferman, MD Ohio State University Columbus, Ohio	Attenuation of Neuroinflammation by Methylene Blue Intervention in a Mouse Model of Traumatic Brain Injury
2013-2015	Bao-Ngoc H. Nguyen, MD George Washington University Washington, DC	The Role of Poly (Adp) Ribose Polymerase During Ischemic and Diabetic Wound Healing Process
2013-2015	Kimberly J. Riehle, MD University of Washington, Seattle, Washington	Improving Regeneration in the Fibrotic Liver
2013-2015	Joseph J. Skitzki, MD Roswell Park Cancer Institute, Buffalo, New York	Quinacrine for the Regional Therapy of Melanoma
2012-2014	Ryan C. Fields, MD Washington University School of Medicine St. Louis, Missouri	Advanced Genetic and Molecular Analysis of Metastatic Colorectal Cancer
2012-2014	James J. Mezhir, MD University of Iowa Hospitals and Clinics Iowa City, Iowa	Extracellular Superoxide Dismutase Alters the Tumor Microenvironment in Pancreatic Cancer
2012-2014	Sunil Singhal, MD University of Pennsylvania Philadelphia, Pennsylvania	Intraoperative Imaging of Lung Cancer
2011-2013	Vishal Bansal, MD University of California San Diego San Diego, California	Unlocking the healing potential of the central nervous system: The role of the vagus nerve following injury
2011-2013	Bryan W. Tillman, MD, PhD University of Pittsburgh Medical Center Pittsburgh, Pennsylvania	Evaluating a Cell Specific Depletion Approach for Circulating Progenitor Cells in the Prevention of Late Vascular Graft Failure
2011-2012	David G. Rabkin, MD University of Washington Medical Center Seattle, Washington	Cytokine removal by hemoadsorption after brain death; effect on ventricular function before and after orthotopic transplantation in a porcine model
2010-2012	Eric C. Liao, MD Massachusetts General Hospital Boston, Massachusetts	Application of Zebrafish Models of Cleft Lip and Palate as Whole-Organism Substrate for Drug Discovery
2010-2012	Tippi C. MacKenzie, MD University of California, San Francisco San Francisco, California	Maternal Immune Responses to Fetal Surgical Intervention
2010-2012	Genevieve Melton-Meaux, MD University of Minnesota Minneapolis, Minnesota	Application of Biomedical Informatics Technologies to the Electronic Health Record to Assess Gastrointestinal Surgical Patient Outcomes
2009-2011	Jen Jen Yeh, MD University of North Carolina Chapel Hill, North Carolina	Targeting the Ras-Ral GEF-Ral Pathway for Pancreatic Cancer Treatment
2009-2011	James O. Park, MD University of Washington Seattle, Washington	Glypican-3 Targeted Nanocarrier-mediated Contrast Magnetic Resonance Imaging Enhances Diagnosis of Indeterminant Hepatocellular Carcinoma Lesions
2009-2011	Caprice Greenberg, MD Brigham & Women’s Hospital Boston, Massachusetts	Institutional Variation in the Surgical Treatment of Early Stage Breast Cancer
2008-2010	Jennifer F. Tseng, MD University of Massachusetts Medical Center Worcester, Massachusetts	Neoadjuvant Strategies for Pancreatic Cancer: A Decision Analysis Model
2008-2010	Rebecca  A. Gladdy, MD, PhD Mount Sinai Hospital Toronto, Ontario	Genetic Mechanisms of Sarcomagenesis
2008-2010	Andrew M. Cameron, MD Johns Hopkins School of Medicine Baltimore, Maryland	Prevention of Recurrent Hepatitis C After Liver Transplantation Using RNA Interference
2007-2009	Michael J. Englesbe, MD University of Michigan Ann Arbor, Michigan	Seasonal Variation in Surgical Quality at Teaching and Non-Teaching Medical Centers in the United States
2007-2009	Robert W. O'Rourke, MD Oregon Health & Sciences University Portland, Oregon	Immunologic Function in Obese Bariatric Surgery Patients
2007-2009	Christopher Wolfgang, MD Johns Hopkins School of Medicine Baltimore, Maryland	Targeting Lipid Mediations of Pancreatic Cancer Growth
2006-2008	Marc G. Jeschke, MD, PhD Shriners Burns Hospital for Children Galveston, Texas	Insulin Administration Improves Hepatic Structure and Function via The P13K/Adt/Wnt/B-catenin
2006-2008	Christopher E. Touloukian, MD Indiana University Indianapolis, Indiana	Enhancing Tumor Immunity by Altering Systemic Antigen Expression
2005-2007	Christopher K. Breuer, MD Yale University School of Medicine New Haven, Connecticut	Investigating the Growth Potential of Tissue Engineered Venous Conduits in a Juvenile Lamb Model
2005-2007	Nita Ahuja, MD Johns Hopkins Hospital Division of Surgical Oncology Baltimore, Maryland	Methylation Profiles in Colorectal Cancer-Utility in Prognosis and Diagnosis
2004-2006	John F. Renz, M.D. New York Presbyterian Hospital Center for Liver Disease and Transplantation New York, New York	The Effect of Heat Shock Protein Expression Upon the Immunogenicity of Human Hepatocellular Carcinoma
2004-2006	Shahab A. Akhter, M.D. University of Cincinnati College of Medicine Cincinnati, Ohio	The role of the Beta-Adrenergic Receptor Kinase in the Development of Hypertrophic Cardiomyopathy
2003-2005	Daniel A. Saltzman, M.D. University of Minnesota Minneapolis, Minnesota	Mechanisms of Tumor Prevention for Attenuated Salmonella
2003-2005	James C. Y. Dunn, M.D. UCLA School of Medicine Los Angeles, California	Intestinal Tissue Engineering for the Treatment of Short Bowel Syndrome
2002-2004	Christopher R. Mantyh, M.D. Duke University Medical Center Durham, North Carolina	Neurogenic Mechanisms of Chronic Colitis
2002-2004	Herbert Chen, M.D. University of Wisconsin Hospital Madison, Wisconsin	Gastrointestinal Neuroendocrine Tumors: A Possible Therapeutic Role for the RAS/RAF Signal Transduction Pathway
2001-2003	Michael S. Mulligan, M.D. University of Washington Seattle, Washington	Role of Chemokines in Ischemia Reperfusion of Lung
2001-2003	James S. Allan, M.D. Massachusetts General Hospital Boston, Massachusetts	The Role of MHC Allopeptides and Indirect Allo-recognition in the Pathogenesis of Chronic Lung Rejection
2000-2002	Gilbert R. Upchurch, Jr., M.D. University of Michigan School of Medicine Ann Arbor, Michigan	Activation of Matix Metalloproteinases During Aneurysm Formation is Nitric Oxide Dependent
2000-2002	Robert C. Gorman, M.D. Hospital University of Pennsylvania Philadelphia, Pennsylvania	Surgery for Post-Infarction Left Ventricular Remodelling
1999-2001	Vivian Gahtan, M.D. Yale University School of Medicine New Haven, Connecticut	Molecular Basis of Vascular Smooth Muscle Cell Migration: Thrombospondin-1 as a Paradigm
1998-2000	John A. Goss, M.D. Baylor College of Medicine Houston, Texas	Infectious Tolerance and Its Role in Intrathymic Tolerance
1997-1999	Michael S. Conte, M.D. Brigham and Women's Hospital Boston, Massachusetts	Endothelial Restoration and Vascular Remodeling
1996-1998	Bruce R. Rosengard, M.D. University of Pennsylvania Medical Center Philadelphia, Pennsylvania	Two-Way Cell Trafficking and Microchimerism: Mechanisms of Rejection and Tolerance in Response to Solid Organ and Cellular Transplants
1994-1996	Ronald J. Weigel, M.D., Ph.D. Stanford University School of Medicine Stanford, California	Transcriptional Regulation of Estrogen Receptor in Breast Carcinoma
1992-1994	Jonathan S. Bromberg, M.D., Ph.D. University of Michigan Medical Center Ann Arbor, Michigan	Anti-CD2 and Anti-CD3 Monoclonal Antibodies Synergize to Prolong Allograft Survival with Decreased Side Effects
1990-1992	B. Mark Evers, M.D. University of Texas Medical Branch Galveston, Texas	Effect of GI Hormones on Growth of Normal and Neoplastic Gut Tissue
1988-1990	Lawrence Rosenberg, M.D. Montreal General Hospital Montreal, Quebec, CANADA	Islet Cell Differentiation in the Hamster Pancreas
1986-1988	Ronald G. Tompkins, M.D. Massachusetts General Hospital Boston, Massachusetts	Hybrid Artificial Liver Using Gel Entrapped Hepatocytes
1984-1986	Michael E. Shapiro, M.D. Beth Israel Deaconess Medical Center Boston, Massachusetts	Immune Regulation of Intraabdominal Abscesses
1982-1984	Dana K. Andersen, M.D. Yale University School of Medicine New Haven, Connecticut	Studies on the Pathophysiologic Role of Gastric Inhibitory Polypeptide (GIP) in Medically and Surgically Induced Changes in Glucose Metabolism